Quid Pro Quo? FDA Architect of Preemption gets hired by Glaxo

Ed Silverman describes Daniel Troy as the preemption prince - I can’t think of a better name for him myself: The preemption prince is joining the big drugmaker as senior vice president and general counsel on September 2. This is a coup for Glaxo, because Troy is widely known - some might say notorious - for being supportive of the pharmaceutical industry. During his tenure as FDA chief counsel, Troy instructed agency staff to issue fewer warning letters in the belief that the missives were being ignored, which resulted critics say led to less effective enforcement of advertising violations. He also laid the groundwork for the current legal battle over preemption, which says FDA approval supercedes state law claims challenging safety, efficacy, or labeling. Drugmakers and the FDA argue preemption exists by maintaining agency actions are the final word on safety and effectiveness. Source: Glaxo Hires Former FDA Chief Counsel Dan Troy // Pharmalot One would assume tha...